View in EDS

Implications of subclinical tuberculosis for vaccine trial design and global effect.

Saved in:
Bibliographic Details
Title: Implications of subclinical tuberculosis for vaccine trial design and global effect.
Authors: Churchyard GJ; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org., Houben RMGJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Fiore-Gartland AL; University of Washington, Seattle, WA, USA., Esmail H; MRC Clinical Trials Unit, University College London, London, UK; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Rangaka MX; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Behr M; McGill International TB Centre, McGill University, Montreal, QC, Canada., Garcia-Basteiro AL; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., Wong EB; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mave V; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India., Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Hanekom WA; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Source: The Lancet. Microbe [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. Date of Electronic Publication: 2024 Jul 01.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101769019 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-5247 (Electronic) Linking ISSN: 26665247 NLM ISO Abbreviation: Lancet Microbe Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38964359
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Implications of subclinical tuberculosis for vaccine trial design and global effect.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Churchyard+GJ%22">Churchyard GJ</searchLink>; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org.<br /><searchLink fieldCode="AU" term="%22Houben+RMGJ%22">Houben RMGJ</searchLink>; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Fielding+K%22">Fielding K</searchLink>; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Fiore-Gartland+AL%22">Fiore-Gartland AL</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Esmail+H%22">Esmail H</searchLink>; MRC Clinical Trials Unit, University College London, London, UK; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Grant+AD%22">Grant AD</searchLink>; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Rangaka+MX%22">Rangaka MX</searchLink>; MRC Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Behr+M%22">Behr M</searchLink>; McGill International TB Centre, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Garcia-Basteiro+AL%22">Garcia-Basteiro AL</searchLink>; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Wong+EB%22">Wong EB</searchLink>; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Hatherill+M%22">Hatherill M</searchLink>; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Mave+V%22">Mave V</searchLink>; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India.<br /><searchLink fieldCode="AU" term="%22Dagnew+AF%22">Dagnew AF</searchLink>; Gates Medical Research Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Schmidt+AC%22">Schmidt AC</searchLink>; Gates Medical Research Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hanekom+WA%22">Hanekom WA</searchLink>; Division of Infection and Immunity, University College London, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa.<br /><searchLink fieldCode="AU" term="%22Cobelens+F%22">Cobelens F</searchLink>; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22White+RG%22">White RG</searchLink>; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769019%22">The Lancet. Microbe</searchLink> [Lancet Microbe] 2024 Oct; Vol. 5 (10), pp. 100895. <i>Date of Electronic Publication: </i>2024 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769019 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-5247 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226665247%22">26665247 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Microbe <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38964359
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S2666-5247(24)00127-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100895
    Titles:
      – TitleFull: Implications of subclinical tuberculosis for vaccine trial design and global effect.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Churchyard GJ
      – PersonEntity:
          Name:
            NameFull: Houben RMGJ
      – PersonEntity:
          Name:
            NameFull: Fielding K
      – PersonEntity:
          Name:
            NameFull: Fiore-Gartland AL
      – PersonEntity:
          Name:
            NameFull: Esmail H
      – PersonEntity:
          Name:
            NameFull: Grant AD
      – PersonEntity:
          Name:
            NameFull: Rangaka MX
      – PersonEntity:
          Name:
            NameFull: Behr M
      – PersonEntity:
          Name:
            NameFull: Garcia-Basteiro AL
      – PersonEntity:
          Name:
            NameFull: Wong EB
      – PersonEntity:
          Name:
            NameFull: Hatherill M
      – PersonEntity:
          Name:
            NameFull: Mave V
      – PersonEntity:
          Name:
            NameFull: Dagnew AF
      – PersonEntity:
          Name:
            NameFull: Schmidt AC
      – PersonEntity:
          Name:
            NameFull: Hanekom WA
      – PersonEntity:
          Name:
            NameFull: Cobelens F
      – PersonEntity:
          Name:
            NameFull: White RG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-5247
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: The Lancet. Microbe
              Type: main
ResultId 1